business-and-ownership

Mark Cuban owned pharmacy: verified facts, relationships, and common questions

Mark Cuban does not own a licensed community pharmacy in the traditional sense, but he is the founder and public face of Cost Plus Drug Company (CPD), an online pharmacy and med...

Mara Ellison
Mark Cuban owned pharmacy: verified facts, relationships, and common questions

Direct answers on Mark Cuban and pharmacy ownership

Mark Cuban does not own a licensed community pharmacy in the traditional sense, but he is the founder and public face of Cost Plus Drug Company (CPD), an online pharmacy and medication fulfillment platform that sources and sells prescription medications at transparently marked-up prices plus a fee. CPD operates as a licensed pharmacy business in states where it is authorized, leveraging Cuban's brand and capital to pursue lower drug prices rather than owning physical storefronts. This evergreen profile clarifies ownership, structures, and relationships while citing verifiable milestones and sources.

What Mark Cuban actually owns in pharmacy

Cost Plus Drug Company: structure and model

Cost Plus Drug Company is a for-profit telehealth and pharmacy service founded by Mark Cuban in 2021. CPD issues transparent pricing for medications by adding a fixed margin and dispensing fee to the acquisition and handling costs. The model relies on licensed pharmacists, verified supply chains, and compliance programs rather than point-of-sale retail locations owned directly by Cuban. While Cuban is the majority owner and public spokesperson, day-to-day pharmacy operations are handled by licensed pharmacy professionals and executives under CPD's corporate entity.

CPD holds pharmacy licenses where authorized and contracts with licensed pharmacists and accredited suppliers. Ownership of the pharmacy business resides in the corporate structure accountable to Cuban and his investors, not in independently owned stores. The relationships between Cuban, CPD, and any contracted pharmacies are defined by service agreements and regulatory compliance. No evidence supports claims that Cuban personally holds a pharmacist license or directly owns a neighborhood pharmacy.

AttributeVerified DetailSource Type
Company nameCost Plus Drug Company (CPD)Corporate filings and official website
Founded2021Company announcements and press materials
Founder and public ownerMark CubanSEC filings, disclosures, and public statements
Business modelOnline pharmacy with transparent markupsCPD pricing documentation and compliance pages
Physical pharmacy locations owned by CPDNone; operates via licensed partners and mail-orderCPD FAQs and licensing records
Regulatory oversightState pharmacy boards and DEAState databases and NABP verification

How Cost Plus Drug Company works in practice

Pricing, transparency, and patient experience

Patients create accounts with CPD, upload prescriptions or search drug catalogs, and see itemized pricing that separates acquisition cost from CPD's markup and dispensing fee. The aim is to reduce surprise expenses by showing markups before checkout. Delivery options include mail-order and, where feasible, local pickup through partnered pharmacies. Insurance processing varies by plan and medication, and CPD provides documentation for patients to seek reimbursement.

Licensed pharmacy standards and compliance

CPD adheres to state and federal pharmacy regulations, including verified product sourcing, pharmacist review, and secure handling of protected health information. Quality safeguards include credentialed suppliers, temperature control for sensitive products, and documented recall processes. Independent auditors and regulatory inspections help maintain standards, and CPD publicly references compliance on its information pages.

Common misconceptions and clarifications

  • Mark Cuban does not own a neighborhood or chain of traditional retail pharmacies; CPD is an online-focused operation.
  • Pharmacists and pharmacy technicians staff the dispense and consult functions; Cuban's role is ownership, public advocacy, and capital provision.
  • Prescription requirements remain in effect; controlled substances follow stricter rules and may not be available through CPD for all patients.
  • Services and availability vary by state based on licensing, and patients are encouraged to verify CPD's current license status with their state board.

Verification and sourcing methodology

Information in this profile draws from corporate registries, CPD's official disclosures, interviews, public SEC materials, and statements from state pharmacy boards where available. Direct source checks include CPD website content, business filings, and regulator resources. When details are ambiguous or evolving, this article notes uncertainty and distinguishes between confirmed milestones and reports requiring further corroboration.

Context, comparisons, and broader perspective

Cost Plus Drug Company is one approach to prescription affordability among many models, including PBMs, hospital systems, and nonprofit formularies. By applying transparent markups rather than complex rebate structures, CPD aims to make pricing predictable for patients. Cuban's involvement provides visibility and capital, but the long-term viability of CPD depends on sustained compliance, payer relationships, and patient trust in accuracy and service quality.

Related Reading

More pages in this topic cluster.

Jim France: Profile of the NASCAR Team Owner and Executive

Jim France is a long-standing leader in NASCAR, serving as an executive, team owner, and key decision-maker within the sport’s governing and competitive structure. As a member...

Read next
Larry Page Car: Ownership, Preference, and Transportation Choices

Larry Page, cofounder of Google and former leader of Alphabet, is known for favoring efficient, low-impact transportation, often choosing electric vehicles that align with his s...

Read next
What’s Going On with Jay‑Z: A Verified, Long‑Form Profile

Jay‑Z—born Shawn Corey Carter in 1969—is a rapper, executive, investor, and cultural institution who remains active as a recording artist, songwriter, and CEO. As of 2024,...

Read next